Listen

Pause Resume

Swiss pharmaceutical group Lonza Group AG will establish a Global Capability Centre (GCC) in Hyderabad, India, the company said on [Date]. The centre will be a key part of Lonza’s global network, leveraging the city’s strong talent pool, quality infrastructure, and supportive industrial ecosystem.

A delegation from Lonza, led by senior officials, met Minister for Industries D Sridhar Babu and CEO of Telangana Lifesciences Shakthi M Nagappan to formally convey the decision on the new GCC. The meeting highlighted the state’s commitment to supporting innovation-led growth in the biopharmaceutical industry.

“Lonza’s investment further strengthens Telangana’s position as a preferred destination for innovation-led growth in the global biopharmaceutical industry. I am delighted that the centre has the potential to create a substantial number of new jobs over the years. We remain committed to supporting such endeavours that promise job creation for our citizens,’’ Sridhar Babu said in a release.  

The decision to set up the GCC in Hyderabad follows an extensive evaluation process, during which the city emerged as a top contender due to its skilled workforce, robust infrastructure, and favourable business environment. The centre will contribute to the generation of high-value employment and further integrate Hyderabad into the global biopharmaceutical value chain.

Shakthi M Nagappan, CEO, Telangana Lifesciences, said, “This decision marks another significant milestone in the continued expansion of Telangana’s life sciences ecosystem. We look forward to working closely with Lonza to ensure the successful execution of this project and to enable long-term value creation.’’

Headquartered in Switzerland and founded in 1897, Lonza operates across more than 30 sites worldwide, employing close to 20,000 professionals. In 2025, the company reported sales of CHF 6.5 billion and a Core EBITDA of CHF 2.1 billion.

The new GCC will be a key part of Lonza’s global strategy, enabling the company to leverage India’s growing life sciences sector and expand its presence in the region. The centre is expected to drive innovation, collaboration, and growth in the biopharmaceutical industry, cementing Hyderabad’s position as a hub for life sciences innovation.